FDA Inspection 1099755 — Idaho Center for Reproductive Medicine

Idaho Center for Reproductive Medicine — FEI 3007327551

The FDA completed an inspection of Idaho Center for Reproductive Medicine on July 10, 2019 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 10, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Boise, ID (United States)